Article
Impact of ABCB1 single-nucleotide polymorphisms on treatment outcomes with salmeterol/fluticasone combination therapy for stable chronic obstructive pulmonary disease.
Genetic testing and molecular biomarkers - 1 Oct 2015
Wang Xin-Wei, Zhang Yan-Lin, Xiong Ying
Abstract excerpt
OBJECTIVES: To investigate the relationship between ABCB1 single-nucleotide polymorphisms and the efficacy of salmeterol/fluticasone combination (SFC) inhalation therapy for stable chronic obstructive pulmonary disease (COPD) in a Chinese Han population. METHODS: A total of 362 patients with stab...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
